Port-wine birthmarks (PWBs), often referred to as port-wine stains or capillary malformations, are progressive malformations composed of capillaries and post-capillary venules. They occur in up to 0.3% of newborns, present at birth as a pink to red patch, and often involve cosmetically sensitive areas including the face. 1 Over time, many PWBs darken in color, acquire secondary changes, including nodules and pyogenic granulomas, and develop soft-tissue hypertrophy that may involve underlying structures. 2,3 PWBs are now known to be caused by somatic mosaic mutations in genes that control cell-cycle regulation, including GNAQ, GNA11, PiK3CA, and others that are also implicated in cell-cycle signaling. 4 This finding has transformed our fundamental understanding of their pathophysiology, as these genes share oncogenic pathways that result in synchronous, tightly regulated cellular proliferation and growth. PWB can be isolated, or syndrome-associated, including Sturge-Weber syndrome (SWS), phakomatosis pigmentovascularis (PPV), or PiK3CA-related overgrowth syndromes (PROS). Genotypephenotype correlations exist for the most common mutations in vascular stains (GNAQ, GNA11, and PiK3CA hot spot, Figure 1). 4 While detailed mechanisms are not yet characterized, causative gain-offunction somatic mosaic mutations may explain the progressive development of nodularity, soft-tissue hypertrophy, and secondary vascular change of PWBs. [4][5][6] Given the progressive disfigurement associated with PWBs, parents often seek early treatment with laser and other light-based modalities. Early treatment of PWBs reduces the likelihood and severity of disfigurement and psychosocial morbidity. 3,7 In particular, the development of vascular-selective lasers led to a therapeutic shift in the management of PWBs and remains the first-line standard of treatment. In this article, we review principles of light-based treatment for pediatric port-wine birthmarks.
| Selective photothermolysisThe use of lasers to treat vascular lesions relies on the theory of selective photothermolysis (SP); chromophores or light-absorbing targets can be targeted, heated, and damaged with minimal injury to the surrounding structures (Figure 2A). 8 For PWBs, the light-absorbing targets are oxyhemoglobin (absorption peaks at 418, 542, and 577 nm), deoxyhemoglobin (absorption peak between 750 and 800 nm), or methemoglobin (absorption at 620 nm, Figure 2B). 9 Three elements are necessary to achieve desired clinical effects in PWB lesions. First, the wavelength chosen must be preferentially